Deal Spree Continues as Celgene Nabs Juno in $9B Deal Post author:Sam Post published:January 21, 2018 Post category:BioPharma The announcement sent shares of Juno soaring more than 27 percent in pre-market trading to $86.26. Source: BioSpace You Might Also Like How GlycoMimetics Defied a Hematology Biotech Pitfall While Its Peers Fell December 12, 2017 Abiomed Fourth Quarter Fiscal 2017 Earnings And Conference Call Notification April 12, 2017 Five Prime Tanked on Early Peek of Lead Drug Data November 7, 2017